Neurology

    Overview

    Neurology is a branch of medicine dedicated to treating disorders of the nervous system.

    Neurologists at SIU Medicine are certified by the American Board of Psychiatry and Neurology, and each emphasizes a particular sub-specialty of neurology, allowing us as a group to maintain an overall excellence comparable to any in the nation. The care of our physicians is complemented by an excellent and highly experienced staff of nurse practitioners, nurses, and support personnel. In addition, our patients benefit from the efforts of various learners of neurology--SIU Neurology resident physicians and medical students.

    In addition to general neurologic care, the Department features several comprehensive programs in Alzheimer's Disease, Epilepsy, Muscular Dystrophy, Multiple Sclerosis, Neurorehabilitaton, Parkinson's Disease and Movement Disorders and Stroke. There are also many ongoing clinical trials to study new therapies for these conditions.

    The neurology department at SIU Medicine is known for its innovative research in neuroscience and clinical therapeutics.

    Our doctors

    Provider

    Thomas Ala, MD

    Medical Director of the Alzheimer's Center Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Hesham Allam, MD

    Neurologist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Abdullah AlSawaf, MD

    Neurologist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Jennifer Arnold, MD

    Neurologist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Bilal Butt, MD

    Neurologist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Tosha Donnals, FNP-BC

    Family Nurse Practitioner Neurology
    Provider

    Ahmad El Kouzi, MD

    Movement Disorders Specialist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Rodger Elble, MD

    Neurologist Neurology
    415 N. 9th St. 2nd Floor Suite 2W94 Springfield, IL 62701
    Provider

    Deidra Frisbie, FNP-C

    Certified Nurse Practitioner Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    James Gilchrist, MD

    Executive Director, Neuroscience Institute Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Louis Graham, MD

    Physiatrist and Rehab Physician Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Carlos Illingworth, MD

    Neurocritical Care and Stroke specialist Neurology
    Provider

    Ann Jirmasek, BS, MA, LPC, NCC

    Clinical Gerontology Specialist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Jeremy Kulacz, MD

    Neurologist Neurology
    ,
    Provider

    Jacob Monsivais, PA-C

    Certified Physician Assistant Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Sajjad Mueed, MD

    Director, Memorial Medical Center Stroke Center Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Chinmay Patel, DO

    Pediatric Neurologist Neurology, Emergency Medicine, Pediatrics
    400 N. 9th Street Springfield, IL 62702
    Provider

    Andrea Perkins, FNP-BC

    Certified Nurse Practitioner Neurology
    Provider

    Jordan Sestak, MD

    Physical Medicine and Rehabilitation Specialist Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Cindy Womack, DNP, FNP-BC, CNRN

    Certified Nurse Practitioner Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Provider

    Charlene Young, FNP-BC

    Certified Nurse Practitioner Neurology
    751 N. Rutledge St. Suite 3100 Springfield, IL 62702

    Why SIU

    Continually learning

    With a focus on continual improvement, our doctors take the time to research, study and innovate to provide the latest treatments for our patients.

    Patient-first experience

    Our care ranges from primary care physicians to specialists and sub-specialists who have advanced training. We're here for you when you need us.

    Breakthrough technology

    Continually teaching the next generation of doctors, our physicians use the latest developments in procedures and technologies for our patients.

    Our Locations

    Place

    SIU Neurology at HSHS St. John's

    415 N. 9th St. 2nd Floor Suite 2W94 Springfield, IL 62701
    Mon - Fri: 8:00 am-4:30 pm
    Place

    SIU Neurology Clinic - Moy Building

    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Mon - Fri: 8:00 am-4:30 pm
    Place

    SIU Neuroscience Institute

    751 N. Rutledge St. Suite 3100 Springfield, IL 62702
    Mon - Fri: 8:00 am-4:30 pm
    Place

    SIU Pulmonology in Decatur

    102 W. Kenwood Ave. Lower Level Decatur, IL 62526
    Mon - Fri: 8:00 am-4:30 pm

    Clinical trials

    Trial
    Neurology

    MDA: Neuromuscular Observational Research

    Active recruiting

    MOVR:  Data Hub is the first and only data hub that aggregates clinical, genetic, and patient reported data for multiple nuromuscular diseases.  Collection of patient data about disease progression in the era of new treatments will inform and accelerate future innovation.  The combination of data collected through MOVR Data Hub will provide a comprehensive understanding of health and patient experiences in a single data repository.  MOVR Data Hub has the power to transform health outcomes, accelerate drug development and drive clinical research across multiple neuromuscular diseases, helpin

    Trial
    Neurology

    Portola: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    ANNEXa-1 (18-513): This is a randomized, multicenter clinical trial designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracerebral hemorrhage within 6 hours of symptom onset (from the baseline scan) and within 15 hours of taking an oral FXa inhibitor (from randomization). The study will use a prospective, randomized, open-label design, as it is unfeasible to blind the Investigator to the treatment assignment given the many potential therapeutic options available under usual care treatment.